DNA Testing Market Increasing Size, Demand, Growth Rate, And Forecast 2033 - Emergen Research
The DNA Testing market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion in 2033, at a CAGR of 23.20%.
Turning Tragedy into Action: A Family's Fight for Genetic Awareness
When we can play any part in supporting other families, it’s a tragic gift that allows us to continue to parent Havi.” For ...
Myriad Genetics (NASDAQ:MYGN) Given New $14.00 Price Target at Piper Sandler
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price cut by analysts at Piper Sandler from $24.00 to $14.00 in a research note issued on Thursday,Benzinga reports. The brokerage ...
Gene Panel Market Size To Worth USD 13.2 Billion By 2030 With A 20.02 % CAGR By Exactitude Consultancy
The gene panel market is expected to grow at 20.02 % CAGR from 2023 to 2030. It is expected to reach above USD 13.2 billion by 2030 from USD 3.02 billion in 2023. List of the Top Key Players of the ...
Controversial genetics testing startup Nucleus Genomics raises $14M Series A
The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
The Economist4d
Heritable Agriculture, a Google spinout, is bringing AI to crop breeding
By reducing the cost of breeding, the firm hopes to improve yields and other properties for an array of important crops ...
Many animals and plants are losing their genetic diversity, making them more vulnerable
A surprisingly trend was that we saw genetic diversity declining even among” many species that aren’t considered at risk, ...
Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...
The Bakersfield Californian5d
Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...